Interview wth Dr. José Hernández-Rodríguez, consultant in the Autoimmune Diseases Service at the Hospital Clínic de Barcelona.
On 25 February 2020, the first patient diagnosed with COVID-19 in Catalonia was admitted to the Intensive Care Unit at the Hospital Clínic de Barcelo1
The Hospital Clínic de Barcelona has incorporated a new robot to improve the detection of skin cancer. It is the Vectra WB360, a device that combines1
The aim is to vaccinate as many professionals as possible as quickly as possible.
Once again, the institutional commitment of the Clinic to the recovery of the health of women victims of sexual violence is reaffirmed.
The biotechnological pharmaceutical company HIPRA has received authorization from the Spanish Agencyfor Medicines and Health Products (AEMPS) to sta1
This Thursday, November 11, Dr. Antoni Trilla, head of the Preventive Medicine and Epidemiology Service at the Hospital Clínic de Barcelona, has re1
This year, the campaign places the emphasis on the combined protection provided by the flu vaccine and the COVID-19 vaccine.
The results show that people with HIV with chronic comorbidities and an unsuppressed HIV viral load could be at greater risk of developing severe COV1
A trial carried out entirely in Catalonia has shown that therapy with dolutegravir plus lamivudine has an efficacy similar to that of triple therapy.1
